Migrating cancer stem cells - An integrated concept of malignant tumour progression

Nature Reviews Cancer

Volumn 5, Issue 9, 2005, Pages 744-749

  Brabletz, Thomas ^a   Jung, Andreas ^a   Spaderna, Simone ^a   Hlubek, Falk ^a   Kirchner, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; WNT PROTEIN;

BREAST CANCER; CANCER RECURRENCE; CARCINOGENESIS; CARCINOMA; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CORRELATION ANALYSIS; DISEASE SEVERITY; GENETIC PARAMETERS; HUMAN; LIVER METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TUMOR GROWTH; ANIMAL; BIOLOGICAL MODEL; CELL MOTION; COLORECTAL TUMOR; METABOLISM; NEOPLASM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL MOVEMENT; COLORECTAL NEOPLASMS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; STEM CELLS;

EID: 25444495269     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrc1694     Document Type: Review

References (56)

1. Pardal, R., Clarke, M. F. & Morrison, S. J. Applying the principles of stem-cell biology to cancer. Nature Rev. Cancer 3, 895-902 (2003).
2. Thiery, J. P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 15, 740-746 (2003).
3. Brabletz, T. et al. Variable β-catenin expression in colorectal cancer indicates tumour progression driven by the tumour environment. Proc. Natl Acad. Sci. USA 98, 10356-10361 (2001).
4. Barker, N. & Clevers, H. Tumour environment: a potent driving force in colorectal cancer? Trends Mol. Med. 7, 535-537 (2001).
5. Bissell, M. J. & Radisky, D. Putting tumours in context. Nature Rev. Cancer 1, 46-54 (2001).
6. Morin, P. J. et al. Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
7. Hülsken, J. & Behrens, J. The Wnt signalling pathway. J. Cell Sci. 115, 3977-3978 (2002).
8. Fuchs, E., Tumbar, T. & Guasch, G. Socializing with the neighbors: stem cells and their niche. Cell 116, 769-778 (2004).
9. Kielman, M. F. et al. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signalling. Nature Genet. 32, 594-605 (2002).
10. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. & Brivanlou, A. H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signalling by a pharmacological GSK-3-specific inhibitor. Nature Med. 10, 55-63 (2004).
11. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nature Genet. 19, 379-383 (1998).
12. He, X. C. et al. BMP signalling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signalling. Nature Genet. 36, 1117-1121 (2004).
13. Gat, U., DasGupta, R., Degenstein, L. & Fuchs, E. De novo hair follicle morphogenesis and hair tumours in mice expressing a truncated β-catenin in skin. Cell 95, 605-614 (1998).
14. Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. & Birchmeier, W. β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105, 533-545. (2001).
15. Reya, T. et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423, 409-414 (2003).
16. Angerer, L. & Angerer, R. Regulative development of the sea urchin embryo: signalling cascades and morphogen gradients. Semin. Cell Dev. Biol. 10, 327-334 (1999).
17. Liebner, S. et al. β-catenin is required for endothelial-mesenchymal transformation during heart cushion development in the mouse. J. Cell Biol. 166, 359-367 (2004).
18. Muller, T., Bain, G., Wang, X. & Papkoff, J. Regulation of epithelial cell migration and tumour formation by β-catenin signalling. Exp. Cell Res. 280, 119-133 (2002).
19. Kim, K., Lu, Z. & Hay, E. D. Direct evidence for a role of β-catenin/LEF-1 signalling pathway in induction of EMT. Cell Biol. Int. 26, 463-476 (2002).
20. Mariadason, J. M. et al. Down-regulation of β-catenin TCF signalling is linked to colonic epithelial cell differentiation. Cancer Res. 61, 3465-3471 (2001).
21. Naishiro, Y. et al. Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation. Cancer Res. 61, 2751-2758 (2001).
22. Conacci-Sorrell, M. et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signalling, Slug, and MAPK. J. Cell Biol. 163, 847-857 (2003).
23. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994).
24. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100, 3983-3988 (2003).
25. Bissell, M. J. & Labarge, M. A. Context, tissue plasticity, and cancer: are tumour stem cells also regulated by the microenvironment? Cancer Cell 7, 17-23 (2005).
26. Jordan, C. T. Cancer stem cell biology: from leukemia to solid tumours. Curr. Opin. Cell Biol. 16, 708-712 (2004).
27. Xue, C., Plieth, D., Venkov, C., Xu, C. & Neilson, E. G. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res. 63, 3386-3394 (2003).
28. Savagner, P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23, 912-923 (2001).
29. Thiery, J. P. Epithelial-mesenchymal transitions in tumour progression. Nature Rev. Cancer 2, 442-454 (2002).
30. Eger, A. et al. β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition. Oncogene 23, 2672-2680 (2004).
31. Brabletz, T., Herrmann, K., Jung, A., Faller, G. & Kirchner, T. Expression of nuclear β-catenin and c-myc is correlated with tumour size but not with proliferative activity of colorectal adenomas. Am. J. Pathol. 156, 865-870 (2000).
32. Kirchner, T. & Brabletz, T. Patterning and nuclear β-catenin expression in the colonic adenoma-carcinoma sequence: analogies with embryonic gastrulation. Am. J. Pathol. 157, 1113-1121 (2000).
33. INK4A and is a region of low proliferation. Am. J. Pathol. 159, 1613-1617 (2001).
34. Brabletz, T. et al. Downregulation of the homeodomain factor Cdx2 in colorectal cancer by collagen type I: an active role for the tumour environment in malignant tumour progression. Cancer Res. 64, 6973-6977 (2004).
35. He, T.-C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
36. Shtutman, M. et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc. Natl Acad. Sci. USA 96, 5522-5527 (1999).
37. Tetsu, O. & McCormick, F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426 (1999).
38. Zhang, T. et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res. 61, 8664-8667 (2001).
39. Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R. & Altieri, D. C. Survivin and molecular pathogenesis of colorectal cancer. Lancet 362, 205-209 (2003).
40. Gavert, N. et al. L1, a novel target of β-catenin signalling, transforms tumour cells and is expressed at the invasive front of colon cancers. J. Cell Biol. 168, 633-642 (2005).
41. Hlubek, F., Jung, A., Kotzor, N., Kirchner, T. & Brabletz, T. Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin. Cancer Res. 61, 8089-8093 (2001).
42. Ueno, H., Murphy, J., Jass, J. R., Mochizuki, H. & Talbot, I. C. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40, 127-132 (2002).
43. Ueno, H. et al. A new prognostic staging system for rectal cancer. Ann. Surg. 240, 832-839 (2004).
44. Oloumi, A., McPhee, T. & Dedhar, S. Regulation of E-cadherin expression and β-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim. Biophys. Acta 1691, 1-15 (2004).
45. Janda, E. et al. Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signalling pathways. J. Cell Biol. 156, 299-313 (2002).
46. Grunert, S., Jechlinger, M. & Beug, H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nature Rev. Mol. Cell Biol. 4, 657-665 (2003).
47. Vega, S. et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131-1143 (2004).
48. Kajita, M., McClinic, K. N. & Wade, P. A. Aberrant expression of the transcription factors Snail and Slug alters the response to genotoxic stress. Mol. Cell Biol. 24, 7559-7566 (2004).
49. Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell 117, 927-939 (2004).
50. Fujita, N. et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113, 207-219 (2003).
51. Blanco, M. J. et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 21, 3241-3246 (2002).
52. Nakajima, S. et al. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin. Cancer Res. 10, 4125-4133 (2004).
53. Rosivatz, E. et al. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am. J. Pathol. 161, 1881-1891 (2002).
54. McAlhany, S. J. et al. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. Prostate 61, 182-191 (2004).
55. Nieto, M. A. The Snail superfamily of zinc-finger transcription factors. Nature Rev. Mol. Cell Biol. 3, 155-166 (2002).
56. Pantel, K. & Woelfle, U. Micrometastasis in breast cancer and other solid tumours. J. Biol. Regul. Homeost. Agents 18, 120-125 (2004).